0001209191-18-004284.txt : 20180118 0001209191-18-004284.hdr.sgml : 20180118 20180118165219 ACCESSION NUMBER: 0001209191-18-004284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180116 FILED AS OF DATE: 20180118 DATE AS OF CHANGE: 20180118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scribner Matt CENTRAL INDEX KEY: 0001596087 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36309 FILM NUMBER: 18534465 MAIL ADDRESS: STREET 1: 326 BOLLAY DRIVE CITY: GOLETA STATE: CA ZIP: 93117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inogen Inc CENTRAL INDEX KEY: 0001294133 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 326 BOLLAY DRIVE CITY: GOLETA STATE: CA ZIP: 93117 BUSINESS PHONE: 805-562-0500 MAIL ADDRESS: STREET 1: 326 BOLLAY DRIVE CITY: GOLETA STATE: CA ZIP: 93117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-16 0 0001294133 Inogen Inc INGN 0001596087 Scribner Matt C/O INOGEN, INC. 326 BOLLAY DRIVE GOLETA CA 93117 0 1 0 0 EVP, Operations Common Stock 2018-01-16 4 M 0 2500 0.81 A 7297 D Common Stock 2018-01-16 4 S 0 2500 116.1672 D 4797 D Stock Option (right to buy) 0.81 2018-01-16 4 M 0 2500 0.00 D 2022-03-28 Common Stock 2500 15183 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016. Represents the weighted average share price of an aggregate total of 2,500 shares sold in the price range of $115.68 to $116.57 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. /s/ Alison Bauerlein, as Attorney-in-Fact 2018-01-17